These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36047217)

  • 1. [Synthetic Study on Bicyclic Depsipeptides Containing an Intramolecular Disulfide Bond].
    Narita K
    Yakugaku Zasshi; 2022; 142(9):917-926. PubMed ID: 36047217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors.
    Saijo K; Imamura J; Narita K; Oda A; Shimodaira H; Katoh T; Ishioka C
    Cancer Sci; 2015 Feb; 106(2):208-15. PubMed ID: 25492515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of the bicyclic depsipeptide HDAC inhibitors spiruchostatins A and B, 5''-epi-spiruchostatin B, FK228 (FR901228) and preliminary evaluation of their biological activity.
    Narita K; Kikuchi T; Watanabe K; Takizawa T; Oguchi T; Kudo K; Matsuhara K; Abe H; Yamori T; Yoshida M; Katoh T
    Chemistry; 2009 Oct; 15(42):11174-86. PubMed ID: 19760730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Romidepsin (FK228) and its analogs directly inhibit phosphatidylinositol 3-kinase activity and potently induce apoptosis as histone deacetylase/phosphatidylinositol 3-kinase dual inhibitors.
    Saijo K; Katoh T; Shimodaira H; Oda A; Takahashi O; Ishioka C
    Cancer Sci; 2012 Nov; 103(11):1994-2001. PubMed ID: 22924958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis of bicyclic depsipeptides spiruchostatins C and D and investigation of their histone deacetylase inhibitory and antiproliferative activities.
    Narita K; Fukui Y; Sano Y; Yamori T; Ito A; Yoshida M; Katoh T
    Eur J Med Chem; 2013 Feb; 60():295-304. PubMed ID: 23313638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity and pharmacologic characterization of the depsipeptide analog as a novel histone deacetylase/ phosphatidylinositol 3-kinase dual inhibitor.
    Saijo K; Imai H; Chikamatsu S; Narita K; Katoh T; Ishioka C
    Cancer Sci; 2017 Jul; 108(7):1469-1475. PubMed ID: 28406576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel FK228 analogues as potential isoform selective HDAC inhibitors.
    Narita K; Matsuhara K; Itoh J; Akiyama Y; Dan S; Yamori T; Ito A; Yoshida M; Katoh T
    Eur J Med Chem; 2016 Oct; 121():592-609. PubMed ID: 27318982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.
    Yurek-George A; Cecil AR; Mo AH; Wen S; Rogers H; Habens F; Maeda S; Yoshida M; Packham G; Ganesan A
    J Med Chem; 2007 Nov; 50(23):5720-6. PubMed ID: 17958342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total synthesis of burkholdacs A and B and 5,6,20-tri-epi-burkholdac A: HDAC inhibition and antiproliferative activity.
    Fukui Y; Narita K; Dan S; Yamori T; Ito A; Yoshida M; Katoh T
    Eur J Med Chem; 2014 Apr; 76():301-13. PubMed ID: 24589486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer Chemotherapy.
    Pojani E; Barlocco D
    Curr Med Chem; 2021; 28(7):1290-1303. PubMed ID: 32013816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A GSH-resistant FK228 analogue containing a stable disulfide bond.
    Zhan MM; Xing Y; Li Z; Yin F
    Bioorg Chem; 2024 Mar; 144():107119. PubMed ID: 38219481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors from microorganisms: the Astellas experience.
    Masuoka Y; Shindoh N; Inamura N
    Prog Drug Res; 2008; 66():335, 337-59. PubMed ID: 18416310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total Synthesis of Thailandepsin B, a Potent HDAC Inhibitor Isolated from a Microorganism.
    Narita K; Katoh T
    Chem Pharm Bull (Tokyo); 2016; 64(7):913-7. PubMed ID: 27373645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New macrocyclic analogs of the natural histone deacetylase inhibitor FK228; design, synthesis and preliminary biological evaluation.
    Ni M; Esposito E; Raj VP; Muzi L; Zunino F; Zuco V; Cominetti D; Penco S; Dal Pozzo A
    Bioorg Med Chem; 2015 Nov; 23(21):6785-93. PubMed ID: 26481659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma.
    VanderMolen KM; McCulloch W; Pearce CJ; Oberlies NH
    J Antibiot (Tokyo); 2011 Aug; 64(8):525-31. PubMed ID: 21587264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities.
    Wang C; Henkes LM; Doughty LB; He M; Wang D; Meyer-Almes FJ; Cheng YQ
    J Nat Prod; 2011 Oct; 74(10):2031-8. PubMed ID: 21793558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards selective inhibition of histone deacetylase isoforms: what has been achieved, where we are and what will be next.
    Thaler F; Mercurio C
    ChemMedChem; 2014 Mar; 9(3):523-6. PubMed ID: 24730063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities.
    Konstantinopoulos PA; Vandoros GP; Papavassiliou AG
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):711-5. PubMed ID: 16435156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolactamization versus macrolactonization: total synthesis of FK228, the depsipeptide histone deacetylase inhibitor.
    Wen S; Packham G; Ganesan A
    J Org Chem; 2008 Dec; 73(23):9353-61. PubMed ID: 18991384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticolon cancer activity of largazole, a marine-derived tunable histone deacetylase inhibitor.
    Liu Y; Salvador LA; Byeon S; Ying Y; Kwan JC; Law BK; Hong J; Luesch H
    J Pharmacol Exp Ther; 2010 Nov; 335(2):351-61. PubMed ID: 20739454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.